Rodovre, Denmark

Poul Borrevang


Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 21(Granted Patents)


Location History:

  • Rodovre, DK (1976 - 1980)
  • Copenhagen, DK (1988 - 1993)

Company Filing History:


Years Active: 1976-1993

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Poul Borrevang

Introduction

Poul Borrevang is a notable inventor based in Rødovre, Denmark. He has made significant contributions to the field of chemistry, particularly in the development of compounds with potential therapeutic applications. With a total of 6 patents to his name, Borrevang's work has garnered attention for its innovative approaches to central nervous system and cardiovascular effects.

Latest Patents

Among his latest patents are "Substituted 2-imidazolines and use thereof" and "2,3,4,5-tetrahydro-1H-3-benzazepines and CNS affecting use thereof." These patents describe novel compounds that exhibit interesting effects on the central nervous system. Specifically, the 2,3,4,5-tetrahydro-1H-3-benzazepines feature various substituents, including furyl, thienyl, and pyridyl groups, which enhance their pharmacological properties.

Career Highlights

Throughout his career, Poul Borrevang has worked with prominent companies such as Novo Industri A/S and Novo Nordisk A/S. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Erling Guddal and Henning Borge Petersen. Their collaborative efforts have played a crucial role in advancing the research and development of innovative compounds.

Conclusion

Poul Borrevang's contributions to the field of chemistry and his innovative patents highlight his role as a significant inventor. His work continues to influence research in central nervous system and cardiovascular applications, showcasing the importance of innovation in science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…